I-cons.png-1

Safety

Cellagility Biomed has the capability to deliver a highly optimized safety service, externally benchmarked with audited quality assurance. A guarantee of our Safe-iPSC potential for future clinical use.

I-cons

Improved Viability

Cellagility Biomed owns process backed by IP under development in culture medium and cryogenic storage capable of increasing post thaw viability.

I-cons.png-2

Cost Efficiency

The processes designed and implemented by Cellagility Biomed offer an opportunity for a considerable reduction in cost for our clients.

SAFE-iPSC-5™ Test Platform

Cellagility Biomed is soon going to launch its test platform that has multiple test capabilities and will offer 3 tier precision for your cell line screening needs.